Technical Analysis for AVGR - Avinger, Inc.

Grade Last Price % Change Price Change
F 0.78 0.00% 0.00
AVGR closed unchanged on Friday, November 1, 2024, on 29 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 7
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -6.02%
Wide Bands Range Expansion -6.02%
NR7 Range Contraction -6.04%
Narrow Range Bar Range Contraction -6.04%

   Recent Intraday Alerts

Alert Time
Gap Up Closed about 19 hours ago
Gap Up Partially Closed about 19 hours ago
Gapped Up (Partial) about 22 hours ago
Up 3% about 22 hours ago
Fell Below Lower Bollinger Band about 22 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avinger, Inc. Description

Avinger, Inc., a medical device company, designs, manufactures, and sells image-guided, catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD). It offers Lightbox, an imaging console, which enables the use of lumivascular catheters during PAD procedures; Ocelot, a chronic total occlusion (CTO) crossing catheter, which allows physicians to see the inside of an artery during a CTO crossing procedure; Ocelot PIXL, a lower profile CTO-crossing device for below-the-knee arteries; and Ocelot MVRX, a device which offers a tip design for above-the-knee arteries. The company also provides Wildcat, a catheter that facilitates the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention; and Kittycat 2, a catheter that facilitate the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists directly in the United States and Europe. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Imaging Catheter Medical Imaging Interventional Radiology Knee Artery Cordis Interventional Cardiology Percutaneous Peripheral Arterial Disease

Is AVGR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.45
52 Week Low 0.76
Average Volume 276,004
200-Day Moving Average 2.24
50-Day Moving Average 1.00
20-Day Moving Average 0.87
10-Day Moving Average 0.84
Average True Range 0.08
RSI (14) 35.90
ADX 14.96
+DI 18.43
-DI 25.28
Chandelier Exit (Long, 3 ATRs) 1.09
Chandelier Exit (Short, 3 ATRs) 1.00
Upper Bollinger Bands 0.98
Lower Bollinger Band 0.77
Percent B (%b) 0.07
BandWidth 25.00
MACD Line -0.06
MACD Signal Line -0.06
MACD Histogram -0.0043
Fundamentals Value
Market Cap 998.35 Thousand
Num Shares 1.28 Million
EPS -30.21
Price-to-Earnings (P/E) Ratio -0.03
Price-to-Sales 0.48
Price-to-Book 1.56
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.84
Resistance 3 (R3) 0.84 0.83 0.83
Resistance 2 (R2) 0.83 0.81 0.82 0.83
Resistance 1 (R1) 0.80 0.80 0.80 0.80 0.82
Pivot Point 0.79 0.79 0.78 0.79 0.79
Support 1 (S1) 0.76 0.77 0.76 0.76 0.74
Support 2 (S2) 0.75 0.76 0.75 0.73
Support 3 (S3) 0.72 0.75 0.73
Support 4 (S4) 0.72